The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel.
Saved in:
| Title: | The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel. |
|---|---|
| Authors: | Chistiakov DA; Department of Molecular Diagnostics, National Research Center GosNIIgenetika, Moscow, Russia. dimitry.chistiakov@lycos.com, Potapov VA, Smetanina SA, Bel'chikova LN, Suplotova LA, Nosikov VV |
| Source: | Acta diabetologica [Acta Diabetol] 2011 Sep; Vol. 48 (3), pp. 227-35. Date of Electronic Publication: 2011 May 25. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5233 (Electronic) Linking ISSN: 09405429 NLM ISO Abbreviation: Acta Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
